Larsen reported that the expression of HIF1A was significantly higher in BV-resistant colorectal cancer cell xenografts than BV-sensitive xenografts,[17] indicating that upregulation of HIF1A was a potential resistant mechanism for BV. This evidence concerns the gene HIF1A and colorectal cancer.